LTF and Eczematoid dermatitis: (1) Higher scores in cognitive (p < 0.01), motor (p < 0.01), and language functions (p < 0.01) in MFGM group at day 365(2) No group differences were detected (adjusted or unadjusted) in any Bayley-III domain in participants tested at day 545(3) Lower rate of respiratory and gastrointestinal AEs in MFGM + lactoferrin group; no differences in eczema occurrence